KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Current Deferred Revenue (2016 - 2026)

Lam Research has reported Current Deferred Revenue over the past 17 years, most recently at $2.1 billion for Q1 2026.

  • For Q1 2026, Current Deferred Revenue rose 11.1% year-over-year to $2.1 billion; the TTM value through Mar 2026 reached $2.1 billion, up 11.1%, while the annual FY2025 figure was $2.6 billion, 65.35% up from the prior year.
  • Current Deferred Revenue for Q1 2026 was $2.1 billion at Lam Research, down from $2.2 billion in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $2.6 billion in Q3 2025 and troughed at $1.5 billion in Q1 2022.
  • A 5-year average of $1.9 billion and a median of $1.9 billion in 2025 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 127.23% in 2022 and later dropped 18.25% in 2023.
  • Year by year, Current Deferred Revenue stood at $1.6 billion in 2022, then increased by 15.53% to $1.8 billion in 2023, then grew by 7.53% to $1.9 billion in 2024, then rose by 12.28% to $2.2 billion in 2025, then decreased by 3.39% to $2.1 billion in 2026.
  • Business Quant data shows Current Deferred Revenue for LRCX at $2.1 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.6 billion in Q3 2025.